Green Valley Pharmaceuticals Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 1,500

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

  • Investments
  • 1

Green Valley Pharmaceuticals General Information

Description

Developer of pharmaceuticals intended to pioneer carbohydrate drug development and new treatment strategies in the areas of chronic and complex diseases. The company focuses on the research and development of sugar drugs, builds a brain platform, and contributes to patients around the world and develops a health program with brain health as its core value, thereby helping in restoring the quality of life for more patients and their families afflicted by Alzheimer's disease and other diseases.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Number 421 Newton Road, China Free Trade Zone
  • Shanghai
  • China
+86 021
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Parent Company
Corporate Office
  • Number 421 Newton Road, China Free Trade Zone
  • Shanghai
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Green Valley Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Green Valley Pharmaceuticals‘s full profile, request access.

Request a free trial

Green Valley Pharmaceuticals Patents

Green Valley Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2021249503-A1 Disaccharide exo-type β-mannan hydrolase and application thereof Inactive 10-Jun-2020
WO-2021233314-A1 Methods for preparing β-d-(1,4)-mannuronate oligosaccharide and intermediate thereof Inactive 19-May-2020
AU-2020377024-A1 Pharmaceutical composition containing alginate oligosaccharide diacid Active 31-Oct-2019
AU-2020377024-B2 Pharmaceutical composition containing alginate oligosaccharide diacid Inactive 31-Oct-2019
EP-4052711-A1 Pharmaceutical composition containing alginate oligosaccharide diacid Inactive 31-Oct-2019 A61K31/734
To view Green Valley Pharmaceuticals’s complete patent history, request access »

Green Valley Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Green Valley Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Green Valley Pharmaceuticals‘s full profile, request access.

Request a free trial

Green Valley Pharmaceuticals Investments (1)

Green Valley Pharmaceuticals’s most recent deal was a Early Stage VC with JiSiMingZhi for . The deal was made on 02-Feb-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
JiSiMingZhi 02-Feb-2021 Early Stage VC Diagnostic Equipment
To view Green Valley Pharmaceuticals’s complete investments history, request access »

Green Valley Pharmaceuticals FAQs

  • When was Green Valley Pharmaceuticals founded?

    Green Valley Pharmaceuticals was founded in 1996.

  • Where is Green Valley Pharmaceuticals headquartered?

    Green Valley Pharmaceuticals is headquartered in Shanghai, China.

  • What is the size of Green Valley Pharmaceuticals?

    Green Valley Pharmaceuticals has 1,500 total employees.

  • What industry is Green Valley Pharmaceuticals in?

    Green Valley Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Green Valley Pharmaceuticals a private or public company?

    Green Valley Pharmaceuticals is a Private company.

  • What is the current valuation of Green Valley Pharmaceuticals?

    The current valuation of Green Valley Pharmaceuticals is .

  • What is Green Valley Pharmaceuticals’s current revenue?

    The current revenue for Green Valley Pharmaceuticals is .

  • Who are Green Valley Pharmaceuticals’s investors?

    Shanghai Institute of Materia Medica has invested in Green Valley Pharmaceuticals.

  • When was Green Valley Pharmaceuticals acquired?

    Green Valley Pharmaceuticals was acquired on 23-Jan-2026.

  • Who acquired Green Valley Pharmaceuticals?

    Green Valley Pharmaceuticals was acquired by Fosun Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process